HopeStage
Back to all studies
RecruitingNCT07685860

MAO-A PET/CT imaging for diagnosis across MAO-A-related conditions

About this titleRead the official source — NCT07685860
Observational studyAges 18–90ChinaAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 90 years.

What will I do during this study?

You receive one intravenous injection of the imaging tracer 18F-AIPF-1026 and then undergo PET/CT or MRI (magnetic resonance imaging) imaging. The registry describes its use for initial assessment or recurrence detection.

Listed locations
Hefei and 2 more locationsSee all locations and recruitment
Number of visits
One injection followed by imaging is listed.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 25, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
200
Sponsor
Tianjin Medical University
Sponsor type
University
Study type
Observational
Intervention type
DIAGNOSTIC_TEST
Study phase
Not clearly listed
Locations
China
Age range
From 18 Years to 90 Years
Official registry ID
NCT07685860
Official title
Show the full official title

Monoamine Oxidase A PET/CT in Various MAO-A-Related Disease

Recruitment & locations

Currently recruiting

Hefei · Qingdao · Tianjin

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Tianjin Medical University, a university.

Who can participate?

Listed age limits: 18 years to 90 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies